Literature DB >> 21381077

PAK4 is required for regulation of the cell-cycle regulatory protein p21, and for control of cell-cycle progression.

Tanya Nekrasova1, Audrey Minden.   

Abstract

The serine/threonine kinase PAK4 regulates cytoskeletal architecture, and controls cell proliferation and survival. In most adult tissues PAK4 is expressed at low levels, but overexpression of PAK4 is associated with uncontrolled proliferation, inappropriate cell survival, and oncogenic transformation. Here we have studied for the first time, the role for PAK4 in the cell cycle. We found that PAK4 levels peak dramatically but transiently in the early part of G1 phase. Deletion of Pak4 was also associated with an increase in p21 levels, and PAK4 was required for normal p21 degradation. In serum-starved cells, the absence of PAK4 led to a reduction in the amount of cells in G1, and an increase in the amount of cells in G2/M phase. We propose that the transient increase in PAK4 levels at early G1 reduces p21 levels, thereby abrogating the activity of CDK4/CDK6 kinases, and allowing cells to proceed with the cell cycle in a precisely coordinated way.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21381077     DOI: 10.1002/jcb.23092

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  23 in total

Review 1.  Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer.

Authors:  Yang-Guang Shao; Ke Ning; Feng Li
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth.

Authors:  Omran Abu Aboud; Ching-Hsien Chen; William Senapedis; Erkan Baloglu; Christian Argueta; Robert H Weiss
Journal:  Mol Cancer Ther       Date:  2016-07-07       Impact factor: 6.261

Review 3.  PAK signalling during the development and progression of cancer.

Authors:  Maria Radu; Galina Semenova; Rachelle Kosoff; Jonathan Chernoff
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

Review 4.  Structure, biochemistry, and biology of PAK kinases.

Authors:  Rakesh Kumar; Rahul Sanawar; Xiaodong Li; Feng Li
Journal:  Gene       Date:  2016-12-19       Impact factor: 3.688

5.  Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease.

Authors:  Vicki J Hwang; Xia Zhou; Xiaonan Chen; Josephine Trott; Omran Abu Aboud; Kyuhwan Shim; Lai Kuan Dionne; Kenneth J Chmiel; William Senapedis; Erkan Baloglu; Moe R Mahjoub; Xiaogang Li; Robert H Weiss
Journal:  Kidney Int       Date:  2017-05-23       Impact factor: 10.612

6.  Role for p21-activated kinase PAK4 in development of the mammalian heart.

Authors:  Tanya Nekrasova; Audrey Minden
Journal:  Transgenic Res       Date:  2011-12-16       Impact factor: 2.788

7.  Anti-Cancer Activity of PAK4/NAMPT Inhibitor and Programmed Cell Death Protein-1 Antibody in Kidney Cancer.

Authors:  Josephine F Trott; Omran Abu Aboud; Bridget McLaughlin; Katie L Anderson; Jaime F Modiano; Kyoungmi Kim; Kuang-Yu Jen; William Senapedis; Hua Chang; Yosef Landesman; Erkan Baloglu; Roberto Pili; Robert H Weiss
Journal:  Kidney360       Date:  2020-05-28

8.  LC-0882 targets PAK4 and inhibits PAK4-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells.

Authors:  Hong-Yan Zhang; Jian Zhang; Chen-Zhou Hao; Ying Zhou; Jian Wang; Mao-Sheng Cheng; Dong-Mei Zhao; Feng Li
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

9.  Fra-2/AP-1 regulates melanoma cell metastasis by downregulating Fam212b.

Authors:  Guang-Liang Chen; Rui Li; Xiao-Xiang Chen; Juan Wang; Shan Cao; Rui Song; Ming-Chun Zhao; Li-Ming Li; Nicole Hannemmann; Georg Schett; Cheng Qian; Aline Bozec
Journal:  Cell Death Differ       Date:  2020-11-13       Impact factor: 15.828

10.  Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma.

Authors:  D Kesanakurti; C Chetty; D Rajasekhar Maddirela; M Gujrati; J S Rao
Journal:  Cell Death Dis       Date:  2012-12-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.